Impact of negatively charged patches on the surface of MHC class II antigen-presenting proteins on risk of chronic beryllium disease
about
sameAs
Nanotoxicology - a pathologist's perspectiveGenetic variability in susceptibility to occupational respiratory sensitizationGenetic susceptibility testing for beryllium: worker knowledge, beliefs, and attitudesGenetic determinants of sensitivity to beryllium in miceChronic beryllium disease, HLA-DPB1, and the DP peptide binding grooveRelease of beryllium from mineral ores in artificial lung and skin surface fluidsResearch to practice implications of high-risk genotypes for beryllium sensitization and diseaseSpectrum of HLA associations: the case of medically refractory pediatric acute lymphoblastic leukemiaExposure and genetics increase risk of beryllium sensitisation and chronic beryllium disease in the nuclear weapons industryRisk of chronic beryllium disease by HLA-DPB1 E69 genotype and beryllium exposure in nuclear workersPeptide binding to HLA-DP proteins at pH 5.0 and pH 7.0: a quantitative molecular docking studyAn official American Thoracic Society statement: diagnosis and management of beryllium sensitivity and chronic beryllium disease.Recent advances in understanding the biomolecular basis of chronic beryllium disease: a review.The role of lymphocyte proliferation tests in assessing occupational sensitization and disease.
P2860
Q23909944-AE498948-6278-4782-AC44-92678AA206AFQ23910399-786BF1FB-A2D5-475C-8F4B-A551BE419E7CQ23916053-E525E68E-BA65-49D0-A770-25CD3725CC61Q23916753-D65FBE5C-BF47-4756-8EA0-496789E8BBD7Q23917120-FE1E4980-3D93-4E6F-8210-562AEDFEFBF9Q23918028-8E8723CB-B802-42B8-9C12-9AE915199088Q27908555-C19C2EC9-FC58-4BD1-BDAE-690553690FC6Q28384290-74362876-8EDE-44CA-943D-4DD6726DA647Q28389130-63F1BBC8-5ECB-4CD8-A7A3-09A4872E65B3Q28390334-61D4989F-4456-472C-A7B7-FFE05B6A01EAQ28391460-574859C6-5A7E-4672-89FC-E21A701ECAD5Q34447942-B9E7192A-888B-425C-BD31-84B257D23123Q37573667-09F33E10-5C04-4BB2-8DB4-0A94E6F20667Q37981493-D9A9FFA4-AE58-42D7-B4E9-C44A9723F911
P2860
Impact of negatively charged patches on the surface of MHC class II antigen-presenting proteins on risk of chronic beryllium disease
description
2008 nî lūn-bûn
@nan
2008 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Impact of negatively charged p ...... k of chronic beryllium disease
@ast
Impact of negatively charged p ...... k of chronic beryllium disease
@en
Impact of negatively charged p ...... k of chronic beryllium disease
@en-gb
Impact of negatively charged p ...... k of chronic beryllium disease
@nl
type
label
Impact of negatively charged p ...... k of chronic beryllium disease
@ast
Impact of negatively charged p ...... k of chronic beryllium disease
@en
Impact of negatively charged p ...... k of chronic beryllium disease
@en-gb
Impact of negatively charged p ...... k of chronic beryllium disease
@nl
prefLabel
Impact of negatively charged p ...... k of chronic beryllium disease
@ast
Impact of negatively charged p ...... k of chronic beryllium disease
@en
Impact of negatively charged p ...... k of chronic beryllium disease
@en-gb
Impact of negatively charged p ...... k of chronic beryllium disease
@nl
P2093
P2860
P50
P921
P356
P1476
Impact of negatively charged p ...... k of chronic beryllium disease
@en
P2093
Bonnie L Frye
Christine R Schuler
Erin C McCanlies
James A Snyder
James S Ensey
Marcia L Stanton
P2860
P2880
P304
P356
10.1098/RSIF.2007.1223
P407
P577
2008-07-06T00:00:00Z